Task: Answer the multiple-choice question.
Query: Which compound exhibits a -20.105\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) Cn1c(CN2CCCCC2)nc2cc(NC(=O)c3cccc(Br)c3)ccc21
(b) CSCCC(NC(=O)c1ccc([N+](=O)[O-])cc1Cl)C(=O)OCC(=O)NC1CCCC(C)C1C
Answer: a. Cn1c(CN2CCCCC2)nc2cc(NC(=O)c3cccc(Br)c3)ccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(CN2CCCCC2)nc2cc(NC(=O)c3cccc(Br)c3)ccc21
Cn1c(CN2CCCCC2)nc2cc(NC(=O)c3cccc(Br)c3)ccc21
3-bromo-N-[1-methyl-2-(piperidin-1-ylmethyl)benzimidazol-5-yl]benzamide